Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03979547 · ClinicalTrials.gov registry record · NA
EXALT: EXercise Attenuates Liver Tumors Trial
A NA study, sponsored by Milton S. Hershey Medical Center.
- Terminated
- Registry status
- NA
- Development phase
- 3
- Enrollment target
NCT03979547 is a NA study that was terminated before completion, run by Milton S. Hershey Medical Center. The registered enrollment target is 3 participants.
The verdict
NCT03979547, a NA study, was terminated before completion, sponsored by Milton S. Hershey Medical Center.
- TERMINATED
- Registry status
- NA
- Development phase
- 3 participants
- Enrollment target
Study Summary
The overall goal of this proposal is to test the effect of exercise to delay or avert HCC recurrence and gain information regarding the potential molecular mechanisms of HCC tumor inhibition by exercise.
Interventions
- BEHAVIORAL Exercise intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2019-01-03 |
| Est. Completion | 2021-09-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03979547
The ClinicalTrials.gov registry entry for NCT03979547 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Milton S. Hershey Medical Center, which has 396 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Exercise intervention is the first listed.
NCT03979547 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03979547 about?
NCT03979547 is a clinical study titled "EXALT: EXercise Attenuates Liver Tumors Trial". The overall goal of this proposal is to test the effect of exercise to delay or avert HCC recurrence and gain information regarding the potential molecular mechanisms of HCC tumor inhibition by exercise.
What is the current status of trial NCT03979547?
This trial is currently terminated. It is a NA study. The enrollment target is 3 participants. The study started on 2019-01-03. Estimated completion is 2021-09-09.
What interventions are being tested in trial NCT03979547?
The interventions under investigation include: Exercise intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT03979547?
This trial is sponsored by Milton S. Hershey Medical Center, which has 396 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.